Collegium Pharmaceutical, Inc.
US ˙ NasdaqGS ˙ US19459J1043

SecurityCOLL / Collegium Pharmaceutical, Inc.
InstitutionJ. Goldman & Co LP
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
J. Goldman & Co LP ownership in COLL / Collegium Pharmaceutical, Inc.

On November 14, 2025 - J. Goldman & Co LP filed a 13F-HR form disclosing ownership of 0 shares of Collegium Pharmaceutical, Inc. (US:COLL) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 243,448 shares of Collegium Pharmaceutical, Inc.. The current value of the position is $0 USD.

J. Goldman & Co LP has a history of taking positions in derivatives of the underlying security (COLL) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

COLL / Collegium Pharmaceutical, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -100.00 0
2025-08-14 2025-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 243,448 243,448 7,199 0.1724
2021-11-15 2021-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -96,347 -100.00 0 -100.00
2021-08-16 2021-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 96,347 19,790 25.85 2,278 25.58 0.0883
2021-05-17 2021-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 76,557 -69,208 -47.48 1,814 -37.88 0.0583
2021-02-16 2020-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 145,765 76,401 110.15 2,920 102.22 0.1483
2020-11-16 2020-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 69,364 -148,590 -68.17 1,444 -62.14 0.0977
2020-08-14 2020-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 217,954 -156,588 -41.81 3,814 -37.64 0.2362
2020-05-15 2020-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 374,542 259,640 225.97 6,116 158.60 0.7371
2020-02-14 2019-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 114,902 -20,297 -15.01 2,365 52.38 0.1696
2019-11-14 2019-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 135,199 100,200 286.29 1,552 237.39 0.1165
2019-08-14 2019-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 34,999 -200,016 -85.11 460 -87.07 0.0319
2019-05-14 2019-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 235,015 -831,832 -77.97 3,558 -80.58 0.2005
2019-02-13 2018-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 1,066,847 -515,038 -32.56 18,318 -21.44 1.4120
2018-11-14 2018-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 1,581,885 1,301,375 463.93 23,317 248.54 1.6302
2018-08-14 2018-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 280,510 56,486 25.21 6,690 16.88 0.3452
2018-05-15 2018-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 224,024 224,024 5,724 0.2437
2018-02-16 2017-12-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -522,593 -100.00 0 -100.00
2017-11-14 2017-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 522,593 211,593 68.04 5,482 40.89 0.2765
2017-08-14 2017-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 311,000 -33,129 -9.63 3,891 12.39 0.2108
2017-05-15 2017-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 344,129 119,279 53.05 3,462 -1.11 0.1711
2017-02-13 2016-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 224,850 146,850 188.27 3,501 133.09 0.2318
2016-11-14 2016-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 78,000 -21,000 -21.21 1,502 28.05 0.0848
2016-08-15 2016-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 99,000 99,000 1,173 0.0613
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-02-13 2018-12-31 13F COLLEGIUM PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F COLLEGIUM PHARMACEUTICAL COM Call 50,000 737 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.